Log in


International Society for antiviral research

The International Society for Antiviral Research (ISAR) was formally established on May 14, 1987. After many years of skepticism, antiviral chemotherapy had become a reality and there was a need for investigators in the field to periodically assemble with colleagues to exchange information and set up collaborations. ISAR was established to meet this need. In the spring of 1988, a meeting in Williamsburg, Virginia - The International Conference on Antiviral Research - drew more than 400 participants. Following the meeting, the new Society's membership rolls approached 700. It was clear that those in the antiviral research community welcomed the opportunity to have a forum for the exchange of scientific information.

Since those early beginnings, ISAR has become internationally recognized as an organization for scientist in the field and as offering the premiere scientific meeting on antiviral research. The purpose of ISAR's annual meeting is to provide an interdisciplinary forum at which investigators involved in basic, applied, and clinical research worldwide can meet to review recent developments in all areas of antiviral research. The organizers plan a program to meet the needs of chemists, biologists, virologists and clinicians interested in the field.

The current membership of the International Society for Antiviral Research is a Who's Who of scientists involved in antiviral research. 

ISAR Board of Directors

Officers

PRESIDENT:   Kathie Seley-Radtke - 2026

PRESIDENT ELECT:  Luis Schang - 2028

IMMEDIATE PAST PRESIDENT:  Kara Carter - 2024

TREASURER : Brian Gowen - 2024

SECRETARY : Jinhong Chang - 2025

Board Members

Andrea Brancale - 2025

Leen Delang - 2024

María-Jesús Pérez-Pérez - 2023

Jessica Spengler - 2024

Subhash Vasudevan - 2023

Zlatko Janeba - 2025

ISAR Committees

ARCHIVE COMMITTEE: Brian Gentry

CAREER DEVELOPMENT COMMITTEE : Leen Delang

    COMMUNICATIONS & OUTREACH COMMITTEE :  Luis Schang (Chair)

    • Website workgroup:  Andrea Brancale (Chair)
    • Social media workgroup:  Jessica Spengler (Chair)
    • Webinars workgroup:  R.K. (Chair), Robert Jordan, Brent Korba
    • Publication workgroup:  Luis Schang (Chair)
    • Ambassadors program : R.K., Luis Schang, Pei-Yong Shi (Co-Chairs)

    CONFERENCE EXHIBITORS COMMITTEE : Roger Ptak

    DIVERSITY COMMITTEE: Ann Kwong (Chair)

    FINANCE COMMITTEE:  Roger Ptak (Chair)

    NOMINATIONS COMMITTEE : Kara Carter (Chair), Johan Neyts, Katherine Seley-Radtke, Luis Schang

    POSTER AWARD COMMITTEE: Brian Gentry (Chair)

    PROGRAM COMMITTEE:  Luis Schang (Chair), Kara Carter, Jerome Deval, Brian Gentry, Robert Jordan, Justin Julander, Chris Meier, Johan Neyts, Joana Rocha Pereira, Katherine Seley-Radtke, Subhash Vasudevan

    • Abstract Review Workgroup:  Brian Gentry and Justin Julander (Co-Chairs)

    SCIENTIFIC EXCELLENCE AWARDS COMMITTEE: Richard Whitley (Chair)

    THE CHU FAMILY FOUNDATION SCHOLARSHIP FOR WOMEN SCIENTISTS COMMITTEE: Katherine Seley-Radtke (Chair)

    TRAVEL GRANTS COMMITTEE : Jinhong Chang (Chair)

    WOMEN IN SCIENCE COMMITTEE: Rhonda Cardin (Chair)

    About ISAR

    The International Society for Antiviral Research (ISAR) is an internationally recognized organization for scientists involved in basic, applied, and clinical aspects of antiviral research. The Society main event is the annual International Conference on Antiviral Research (ICAR), a truly interdisciplinary meeting which attracts the interest of chemists, biologists, and clinicians.

    ISAR

    info@isaricar.com
    1-571-349-0079


    Powered by Wild Apricot Membership Software